Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Carson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Oncologist|May 29, 2010
Obesity and cancerKathleen Y Wolin, Kenneth Carson, Graham A Colditz
Protein Science : a Publication of the Protein Society|February 22, 2005
Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicitySungmun Lee, Kenneth Carson, Allison Rice-Ficht, et al.
Biochemical and Biophysical Research Communications|July 11, 2006
Small heat shock proteins differentially affect Abeta aggregation and toxicitySungmun Lee, Kenneth Carson, Allison Rice-Ficht, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient CohortKenneth Carson, Seyed Hamidreza Mahmoudpour, Chiemeka Ike, et al.
Thrombosis Research|December 8, 2019
Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancerAmber Afzal, Luo Suhong, Brian F Gage, et al.
Urologic Oncology|March 20, 2013
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?M'Liss A Hudson, Suhong Luo, Timothy Chrusciel, et al.
Journal of Biomolecular Screening|December 5, 2009
Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assaysXuan-Chuan Yu, Maricar Miranda, Ziye Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 10, 2016
Toward a Modern Science of Obesity at Washington University: How We Do It and What is the Payoff?Graham A Colditz, Sarah Gehlert, Deborah J Bowen, et al.
Leukemia & Lymphoma|June 10, 2017
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I studySagun Goyal, Eunhye Oak, Jingqin Luo, et al.
Blood Vessels, Thrombosis & Hemostasis|December 29, 2025
Risk factors for anticoagulant-related bleeding in cancer: traditional and cancer-specific factorsAlexa Loncharich, Brian F Gage, Suhong Luo, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Oncologist|May 29, 2010
Obesity and cancerKathleen Y Wolin, Kenneth Carson, Graham A Colditz
Protein Science : a Publication of the Protein Society|February 22, 2005
Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicitySungmun Lee, Kenneth Carson, Allison Rice-Ficht, et al.
Biochemical and Biophysical Research Communications|July 11, 2006
Small heat shock proteins differentially affect Abeta aggregation and toxicitySungmun Lee, Kenneth Carson, Allison Rice-Ficht, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient CohortKenneth Carson, Seyed Hamidreza Mahmoudpour, Chiemeka Ike, et al.
Thrombosis Research|December 8, 2019
Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancerAmber Afzal, Luo Suhong, Brian F Gage, et al.
Urologic Oncology|March 20, 2013
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?M'Liss A Hudson, Suhong Luo, Timothy Chrusciel, et al.
Journal of Biomolecular Screening|December 5, 2009
Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assaysXuan-Chuan Yu, Maricar Miranda, Ziye Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 10, 2016
Toward a Modern Science of Obesity at Washington University: How We Do It and What is the Payoff?Graham A Colditz, Sarah Gehlert, Deborah J Bowen, et al.
Leukemia & Lymphoma|June 10, 2017
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I studySagun Goyal, Eunhye Oak, Jingqin Luo, et al.
Blood Vessels, Thrombosis & Hemostasis|December 29, 2025
Risk factors for anticoagulant-related bleeding in cancer: traditional and cancer-specific factorsAlexa Loncharich, Brian F Gage, Suhong Luo, et al.
Pageof 2